{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 31 31 97 53", "website": "https://evaxion.ai", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Kanstrup M.Sc.", "age": 52, "title": "Chief Executive Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 422000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 48, "title": "Founder & Chief AI Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 287000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Frederik Schmidt", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 77000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 47, "title": "Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 314000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.85, "open": 1.86, "dayLow": 1.64, "dayHigh": 1.86, "regularMarketPreviousClose": 1.85, "regularMarketOpen": 1.86, "regularMarketDayLow": 1.64, "regularMarketDayHigh": 1.86, "payoutRatio": 0.0, "beta": -0.239, "forwardPE": -1.3174603, "volume": 135044, "regularMarketVolume": 135044, "averageVolume": 2391618, "averageVolume10days": 66210, "averageDailyVolume10Day": 66210, "bid": 1.63, "ask": 1.7, "bidSize": 1, "askSize": 1, "marketCap": 10485506, "fiftyTwoWeekLow": 1.64, "fiftyTwoWeekHigh": 22.05, "priceToSalesTrailing12Months": 3.1822476, "fiftyDayAverage": 2.44386, "twoHundredDayAverage": 9.584635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 97646400, "profitMargins": 0.0, "floatShares": 40728166, "sharesOutstanding": 6316570, "sharesShort": 22395, "sharesShortPriorMonth": 58587, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0034999999, "heldPercentInsiders": 0.055609997, "heldPercentInstitutions": 0.00848, "shortRatio": 0.11, "shortPercentOfFloat": 0.0047, "impliedSharesOutstanding": 6316570, "bookValue": 0.067, "priceToBook": 24.77612, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -11461000, "trailingEps": -14.0, "forwardEps": -1.26, "lastSplitFactor": "1:5", "lastSplitDate": 1736812800, "enterpriseToRevenue": 29.635, "enterpriseToEbitda": -6.565, "52WeekChange": -0.9077778, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.66, "targetHighPrice": 19.75, "targetLowPrice": 6.0, "targetMeanPrice": 13.25, "targetMedianPrice": 14.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 4576000, "totalCashPerShare": 0.083, "ebitda": -14873750, "totalDebt": 0, "totalRevenue": 3295000, "revenuePerShare": 3.566, "returnOnAssets": -0.69451, "grossProfits": 3295000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -0.57375, "financialCurrency": "USD", "symbol": "EVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "marketState": "PRE", "regularMarketChangePercent": -10.270273, "regularMarketPrice": 1.66, "shortName": "Evaxion Biotech A/S", "longName": "Evaxion Biotech A/S", "regularMarketChange": -0.19000006, "regularMarketDayRange": "1.64 - 1.86", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2391618, "fiftyTwoWeekLowChange": 0.01999998, "fiftyTwoWeekLowChangePercent": 0.01219511, "fiftyTwoWeekRange": "1.64 - 22.05", "fiftyTwoWeekHighChange": -20.39, "fiftyTwoWeekHighChangePercent": -0.92471653, "fiftyTwoWeekChangePercent": -90.77778, "earningsTimestamp": 1743507035, "earningsTimestampStart": 1748262600, "earningsTimestampEnd": 1748608200, "earningsCallTimestampStart": 1743510600, "earningsCallTimestampEnd": 1743510600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -14.0, "epsForward": -1.26, "epsCurrentYear": -2.665, "priceEpsCurrentYear": -0.6228893, "fiftyDayAverageChange": -0.7838601, "fiftyDayAverageChangePercent": -0.32074672, "twoHundredDayAverageChange": -7.924635, "twoHundredDayAverageChangePercent": -0.8268061, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.5 - Strong Buy", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_319014926", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null}